tiprankstipranks
Advertisement
Advertisement
Acumen Pharmaceuticals Warns Investors: Unchanged 10-K Risk Factors Still Weigh on Valuation and Share Price
PremiumCompany AnnouncementsAcumen Pharmaceuticals Warns Investors: Unchanged 10-K Risk Factors Still Weigh on Valuation and Share Price
2M ago
Acumen Pharmaceuticals Bets Big on Alzheimer’s Trials
Premium
Company Announcements
Acumen Pharmaceuticals Bets Big on Alzheimer’s Trials
2M ago
Acumen Updates Q1 Results and Alzheimer’s Pipeline Progress
Premium
Company Announcements
Acumen Updates Q1 Results and Alzheimer’s Pipeline Progress
2M ago
Is ABOS a Buy, Before Earnings?
PremiumPre-EarningsIs ABOS a Buy, Before Earnings?
4M ago
Acumen participates in a conference call with Cantor
Premium
The Fly
Acumen participates in a conference call with Cantor
4M ago
Acumen announces new research findings at Alzheimer’s and Parkinson’s conference
Premium
The Fly
Acumen announces new research findings at Alzheimer’s and Parkinson’s conference
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100